Bactiguard Holding First Quarter 2024 Earnings: Beats Expectations

Bactiguard Holding (STO:BACTI B) First Quarter 2024 Results

Key Financial Results

• Revenue: kr58.8m (down 3.9% from 1Q 2023).
• Net loss: kr9.90m (loss narrowed by 55% from 1Q 2023).
• kr0.28 loss per share (improved from kr0.63 loss in 1Q 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Bactiguard Holding Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 13%. Earnings per share (EPS) also surpassed analyst estimates by 58%.

Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Medical Equipment industry in Sweden.

Performance of the Swedish Medical Equipment industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 2 warning signs for Bactiguard Holding you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.